In the aftermath of a recall by a major CPAP manufacturer, Phillips Respironics, there is national CPAP shortage. As a result, oral appliance therapy is being considered as a treatment option more than ever before. The most common therapy for Obstructive Sleep Apnea (OSA) in the United States is positive airway pressure, either a continuous pressure (CPAP) or one that auto adjusts (autoPAP). An alternative option is a mandibular advancement devices (oral appliance) which has been gaining popularity over the last 10 years. Traditionally, CPAP has been the first choice of physicians for treatment of patients with OSA because of its effectiveness …
Category: Oral Device
Sleep Impressions Video
Do you know what we do? How we help our patients? Check out our new video…
OSA Therapy Choice and Compliance
The two most common therapies for Obstructive Sleep Apnea are continuous positive airway pressure (CPAP) and mandibular advancement splints (oral appliance). These two therapies have similar benefits to patients but differ in comfort, ease of use and compliance levels. Traditionally, CPAP has been the first choice of physicians for treatment of patients with OSA. Low CPAP compliance rates and high efficacy results for the oral appliance have physicians reconsidering this choice. Studies show that 30 to 50% of CPAP users are noncompliant. In contrast, oral appliance users report nearly 100% compliance. Noncompliant patients are at risk of stroke, obesity, drowsy …
A Case For The Patient Treatment Pathway For Oral Device Therapy
Featured in the March 2017 edition of Dental Sleep Medicine Insider Magazine is article A Case For The Patient Treatment Pathway For Oral Device Therapy By Jagdeep Bijwadia: 40% of CPAP users are non-complant. That means that for close to half of all patients being treated for Obstructive Sleep Apnea, CPAP simply is not a viable solution. The ideal metric for treatment should take into account both the AHI and… read more